drugset / Trial / NCT00279344

Efficacy and Safety of FITpatch Compared to Standard Opioid Treatment in Cancer Pain (FT-015-IN)

NCT00279344

Phase 3 Completed 220 enrolled Nycomed
RandomizedParallel-groupOpen-labelTreatment

Summary

Primary objectives: * To determine non-inferiority of FITpatch with regard to efficacy compared to standard opioid treatment * To assess the safety of FITpatch compared to standard opioid treatment Secondary objectives: * To assess the intake of oral morphine as rescue analgesic to FITpatch compared to standard opioid treatment * To assess Quality of life reported with FITpatch compared to standard opioid treatment

Timeline

Start
2004-09
Primary completion
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified Other

Indications

No indication recorded.